Immuron ceo steven lydeamore investor webinar presentation

Melbourne, australia, nov. 13, 2023 (globe newswire) -- immuron limited (asx: imc; nasdaq: imrn), an australian based and globally integrated biopharmaceutical company is pleased to invite shareholders to attend an investor webinar on the watchlist, to be held on tuesday, 14th november, 2023, 1:00pm aedt/10:00am awst.
IMRN Ratings Summary
IMRN Quant Ranking